Roshan Kamal Topno
Overview
Explore the profile of Roshan Kamal Topno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jindal N, Kumar A, Bhat A, Madhukar M, Topno R, Pandey K, et al.
Am J Trop Med Hyg
. 2025 Feb;
PMID: 39999449
Rotavirus (RV) is a leading cause of severe gastroenteritis in infants and young children, often resulting in dehydration and hospitalization. Although global data on RV is well-documented, there is limited...
2.
Kumar M, Singh K, Topno R, Madhukar M, Siddiqui N, Sinha S, et al.
Diagn Microbiol Infect Dis
. 2024 Nov;
111(2):116579.
PMID: 39577103
Japanese encephalitis (JE) is the leading cause of acute encephalitis syndromes (AES). Although Bihar has comprehensive data on JE, it ranks third behind Uttar Pradesh and Assam in terms of...
3.
Azam M, Das V, Ramesh V, Gupta T, Topno R, Dixit K, et al.
J Infect Dis
. 2024 Oct;
PMID: 39383212
Post-kala-azar dermal leishmaniasis (PKDL) is a skin condition that occurs in a small percentage of people who have been cured of visceral leishmaniasis (VL), and contributes to transmission of VL....
4.
Siddiqui N, Ansari M, Sinha S, Pal B, Singh A, Singh S, et al.
Am J Trop Med Hyg
. 2024 Oct;
111(6):1198-1205.
PMID: 39378874
An assessment of the treatment outcomes of single-dose liposomal amphotericin B, implemented in 2010, had not been conducted until this study. This prospective cross-sectional study encompassed 527 cases, comprising 470...
5.
Sundar S, Pandey K, Mondal D, Madhukar M, Topno R, Kumar A, et al.
PLoS Negl Trop Dis
. 2024 Jun;
18(6):e0012242.
PMID: 38900786
Background: In Southeast Asia, treatment is recommended for all patients with post-kala-azar dermal leishmaniasis (PKDL). Adherence to the first-line regimen, twelve weeks of miltefosine (MF), is low and ocular toxicity...
6.
Kumar M, Kamaraj P, Khan S, Allam R, Barde P, Dwibedi B, et al.
Lancet Microbe
. 2022 May;
2(1):e41-e47.
PMID: 35544228
Background: Since its re-emergence in 2005, chikungunya virus (CHIKV) transmission has been documented in most Indian states. Information is scarce regarding the seroprevalence of CHIKV in India. We aimed to...
7.
Rabi Das V, Siddiqui N, Bhunia G, Pandey K, Sinha S, Ansari M, et al.
PLoS Negl Trop Dis
. 2021 Aug;
15(8):e0009598.
PMID: 34428232
Background: Visceral leishmaniasis (VL), also known as kala-azar (KA), is a neglected vector-borne disease, targeted for elimination, but several affected blocks of Bihar are posing challenges with the high incidence...
8.
Kumar M, Kamaraj P, Khan S, Allam R, Barde P, Dwibedi B, et al.
Am J Trop Med Hyg
. 2021 Aug;
105(5):1277-1280.
PMID: 34370710
We conducted a nationally representative population-based survey in 60 districts from 15 Indian states covering all five geographic regions during 2017-2018 to estimate the age specific seroprevalence of dengue. Of...
9.
Pandey K, Pal B, Siddiqui N, Lal C, Ali V, Bimal S, et al.
Indian J Dermatol Venereol Leprol
. 2021 Feb;
87(1):34-41.
PMID: 33580944
Background: Treatment of post-kala-azar dermal leishmaniasis cases is of paramount importance for kala-azar elimination; however, limited treatment regimens are available as of now. Aim: To compare the effectiveness of liposomal...
10.
Murhekar M, Kamaraj P, Kumar M, Khan S, Allam R, Barde P, et al.
Lancet Infect Dis
. 2021 Jan;
21(6):868-875.
PMID: 33485469
Background: Diphtheria is re-emerging as a public health problem in several Indian states. Most diphtheria cases are among children older than 5 years. In this study, we aimed to estimate...